Home > Qtrly Results > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Quarterly Results Analysis [Jun2024]

DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Quarterly Results

Consolidated Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Sep2022
UnAudited
Revenues ₹7,696 Cr ₹7,114 Cr ₹7,237 Cr ₹6,903 Cr ₹6,758 Cr ₹6,315 Cr ₹6,790 Cr ₹6,332 Cr
Expenses ₹5,566 Cr ₹5,283 Cr ₹5,214 Cr ₹4,894 Cr ₹4,696 Cr ₹4,781 Cr ₹4,851 Cr ₹4,433 Cr
Operating Income ₹2,130 Cr ₹1,831 Cr ₹2,023 Cr ₹2,008 Cr ₹2,062 Cr ₹1,534 Cr ₹1,939 Cr ₹1,899 Cr
Other Income ₹187 Cr ₹198 Cr ₹216 Cr ₹315 Cr ₹174 Cr ₹139 Cr ₹59 Cr ₹41 Cr
Interest ₹60 Cr ₹59 Cr ₹39 Cr ₹35 Cr ₹37 Cr ₹35 Cr ₹42 Cr ₹31 Cr
Depreciation ₹381 Cr ₹368 Cr ₹374 Cr ₹376 Cr ₹353 Cr ₹316 Cr ₹324 Cr ₹309 Cr
Profit Before Tax ₹1,877 Cr ₹1,602 Cr ₹1,826 Cr ₹1,913 Cr ₹1,846 Cr ₹1,322 Cr ₹1,632 Cr ₹1,600 Cr
Profit After Tax ₹1,387 Cr ₹1,306 Cr ₹1,378 Cr ₹1,478 Cr ₹1,401 Cr ₹953 Cr ₹1,238 Cr ₹1,100 Cr
EPS ₹83.48 ₹78.53 ₹82.79 ₹88.86 ₹84.33 ₹57.63 ₹74.66 ₹66.96
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES -4.1% -6.6% 18.8%
SUN PHARMACEUTICAL INDUSTRIES -2.3% -2.9% 69.8%
CIPLA 3.7% -5.9% 29.5%
ZYDUS LIFESCIENCES -0.3% -6.1% 74.6%
DIVIS LABORATORIES 1.6% 8.7% 74%
MANKIND PHARMA 10.8% 6.3% 53.2%
TORRENT PHARMACEUTICALS -3.2% -5.4% 66.1%
LUPIN -0.3% 0.7% 93.8%
AUROBINDO PHARMA -2.3% -3.9% 64.4%

DR REDDYS LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

8.19 %

Y-o-Y

13.88 %

Quarters Revenues % Change
Jun2024 ₹7,696 Cr
8.19
Mar2024 ₹7,114 Cr
-1.70
Dec2023 ₹7,237 Cr
4.84
Sep2023 ₹6,903 Cr
2.14
Jun2023 ₹6,758 Cr
7.01
Mar2023 ₹6,315 Cr
-6.99
Dec2022 ₹6,790 Cr
7.23
Sep2022 ₹6,332 Cr -

DR REDDYS LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

16.31 %

Y-o-Y

3.29 %

Quarters Operating Profit % Change
Jun2024 ₹2,130 Cr
16.31
Mar2024 ₹1,831 Cr
-9.49
Dec2023 ₹2,023 Cr
0.74
Sep2023 ₹2,008 Cr
-2.61
Jun2023 ₹2,062 Cr
34.44
Mar2023 ₹1,534 Cr
-20.87
Dec2022 ₹1,939 Cr
2.09
Sep2022 ₹1,899 Cr -
Operating Margins
Q-o-Q

7.54 %

Y-o-Y

-9.28 %

Quarters Operating Margin% % Change
Jun2024 27.68%
7.54
Mar2024 25.74%
-7.94
Dec2023 27.96%
-3.88
Sep2023 29.09%
-4.65
Jun2023 30.51%
25.61
Mar2023 24.29%
-14.92
Dec2022 28.55%
-4.80
Sep2022 29.99% -

DR REDDYS LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

6.14 %

Y-o-Y

-1.01 %

Quarters Profit After Tax % Change
Jun2024 ₹1,387 Cr
6.14
Mar2024 ₹1,306 Cr
-5.22
Dec2023 ₹1,378 Cr
-6.75
Sep2023 ₹1,478 Cr
5.52
Jun2023 ₹1,401 Cr
47.06
Mar2023 ₹953 Cr
-23.06
Dec2022 ₹1,238 Cr
12.52
Sep2022 ₹1,100 Cr -
PAT Margins
Q-o-Q

-1.85 %

Y-o-Y

-13.07 %

Quarters PAT Margin(%) % Change
Jun2024 18.02 %
-1.85
Mar2024 18.36 %
-3.57
Dec2023 19.04 %
-11.07
Sep2023 21.41 %
3.28
Jun2023 20.73 %
37.47
Mar2023 15.08 %
-17.28
Dec2022 18.23 %
4.89
Sep2022 17.38 % -

DR REDDYS LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

6.30 %

Y-o-Y

-1.01 %

Quarters EPS % Change
Jun2024 ₹83.48
6.30
Mar2024 ₹78.53
-5.15
Dec2023 ₹82.79
-6.83
Sep2023 ₹88.86
5.37
Jun2023 ₹84.33
46.33
Mar2023 ₹57.63
-22.81
Dec2022 ₹74.66
11.50
Sep2022 ₹66.96 -

You may also like the below Video Courses